共查询到18条相似文献,搜索用时 93 毫秒
1.
目的:探讨胰岛素样生长因子-1(IGF-I)通过磷酯酰肌醇3-激酶/蛋白激酶B(PI-3K/Akt)信号通路对结肠癌细胞株SW480凋亡率的影响及其凋亡抑制蛋白survivin表达水平的变化。方法:培养结肠癌SW480细胞株,实验分成三组:未加IGF-I空白组、IGF-I刺激组、IGF-I+LY294002阻断组,检测阻断剂LY294002是否阻断PI-3K/Akt通路(Western Blot检测三组P-Akt表达情况);Western Blot及免疫荧光观察三组survivin蛋白表达变化;MTT法检测细胞增殖活性,流式细胞术检测细胞凋亡情况。结果:Western blot结果显示LY294002可抑制IGF-I诱导的p-Akt的表达(P〈0.05);阻断IGF-I诱导的PI-3K/Akt通路后MTT显示结肠癌细胞SW480增殖抑制率升高(P〈0.05),流式细胞术分析显示凋亡率明显上升(P〈0.05);Western blot及免疫荧光结果显示LY294002可抑制IGF-I诱导的survivin的表达(P〈0.05)。结论:IGF-I可通过PI-3K/Akt通路诱导survivin表达,从而抑制结肠癌细胞SW480的凋亡。 相似文献
2.
研究表没食子儿茶素没食子酸酯(EGCG)通过PI3-K/Akt信号通路对人甲状腺乳头状癌细胞K1增殖和凋亡的影响。利用MTT法研究不同剂量EGCG对K1细胞的增殖作用;采用流式细胞术分析EGCG对K1细胞周期和凋亡影响;Westernblot方法检测分析EGCG对人甲状腺乳头状癌K1细胞PI3-K、Akt/p-Akt、mTOR、cyclin D1、CDK4、Bcl-2/Bad、cleaved-caspase-3蛋白表达影响。MTT结果显示EGCG作用后K1细胞增殖显著受到抑制,且表现出明显的剂量依赖性和时间依赖性(P0.001);流式细胞术结果显示EGCG能够将K1细胞阻滞于G1期,并且产生剂量依赖性诱导K1细胞凋亡(P0.001);Westernblot结果显示EGCG能够上调K1细胞促凋亡蛋白Bad及cleaved-caspase-3的表达,下调PI3-K、mTOR、cyclin D1、CDK4蛋白表达,降低AKT蛋白磷酸化及抑凋亡蛋白Bcl-2表达(P0.05)。结果证明,EGCG能够通过PI3-K/Akt信号通路,诱导G1阻滞及细胞凋亡,抑制人甲状腺乳头状癌细胞K1增殖。 相似文献
3.
《生命科学研究》2015,(5):432-436
线粒体途径细胞凋亡与多种疾病(如肿瘤、心血管疾病、神经退行性疾病等)密切相关,B淋巴细胞瘤-2(B-cell leukemia-2,Bcl-2)家族蛋白的调控在这些疾病的治疗中起着重要作用。磷脂酰肌醇-3-激酶(phosphatidylinositol-3-kinase,PI3K)/丝/苏氨酸蛋白激酶(serine/threonine protein kinase Akt)信号通路作为机体细胞信号转导的重要通路,可通过影响下游效应分子(Bcl-x L、Bcl-w、Mcl-1、A1、Bax、Bak、Bim、Bad、Bid等)的活性调节细胞的凋亡。就PI3K/Akt与线粒体途径凋亡相关因子的关联性进行综述,以期发现此通路中某些关键的分子靶点,为凋亡相关性疾病的治疗及药物研发提供参考。 相似文献
4.
自噬相关基因Becn1在肺癌等多种肿瘤中处于低表达状态,具有抑制肿瘤发生发展的作用。目前,已有研究发现Becn1可以通过自噬途径参与调控肺癌的发生发展过程,且细胞自噬还与凋亡关系密切。但是,Becn1在调控肺癌发生发展过程中涉及的凋亡过程和相关机制尚未完全阐明。本研究选用肺癌细胞系PC9和A549,建立Becn1高表达的肺癌细胞模型,采用蛋白质免疫共沉淀实验和GFP-BECLIN1、DsRed-Mit荧光共定位实验首次证实了Becn1可通过线粒体途径参与调控肺癌细胞的凋亡过程。 相似文献
5.
该研究通过构建高表达胰岛素生长因子-1(insulin-like growth factor-1,IGF-1)的异常微环境模型探讨IGF-1对骨髓间充质干细胞(bone mesenchymal stem cells,BMSCs)凋亡的影响及可能的作用机制,为BMSCs作为载体在靶向治疗肿瘤过程中的安全应用提供前期实验基础。取分离纯化的大鼠BMSCs,用流式细胞术鉴定BMSCs表面标志,将实验分为4组:BMSCs空白对照组、IGF-1刺激组、IGF-1+LY294002阻断剂组和IGF-1+MK2206阻断剂组。加药处理2周后,CCK-8法检测细胞增殖能力;Hoechst 33342染色观察细胞核形态及凋亡比例;流式细胞术检测细胞凋亡和细胞线粒体膜电位变化;RT-qPCR检测细胞Akt、Bad、Bcl-xl、c-Myc、STAT3的m RNA水平;Western blot检测细胞Akt、p-Akt、Bad、p-Bad、Bcl-xl、c-Myc、STAT3、p-STAT3的蛋白水平。结果显示:IGF-1刺激组细胞与BMSCs空白对照组比较增殖率升高,凋亡率减低;IGF-1刺激组Bad、Bcl-xl、cMyc、STAT3的mRNA的表达均显著高于BMSCs空白对照组(P0.05);IGF-1刺激组p-Akt、Bad、p-Bad、Bcl-xl、c-Myc、STAT3、p-STAT3的蛋白表达水平显著高于BMSCs空白对照组(P0.05)。而阻断剂组细胞(IGF-1+LY294002阻断剂组、IGF-1+MK2206阻断剂组)与IGF-1刺激组比较增殖率均降低,凋亡率增高,相关分子m RNA和蛋白表达水平均明显降低。以上结果表明,IGF-1能通过活化PI3K/Akt通路,激活下游增殖和凋亡相关分子,从而促进BMSCs增殖,抑制BMSCs凋亡。 相似文献
6.
目的:研究蛋白酶体抑制剂硼替佐米对结肠癌SW480细胞凋亡作用,并进一步探讨其作用机制.方法:硼替佐米1-500nmol/L处理结肠癌SW480细胞24-48小时,MTT法检测细胞存活率、药物IC50值.流式细胞术检测细胞凋亡率.Western blot技术检测caspase-3,p-Akt和PTEN蛋白表达水平变化.结果:硼替佐米以时间-剂量依赖方式抑制结肠癌SW480细胞增殖,48小时IC50值:87.36 nmol/L.细胞凋亡实验显示药物作用24小时细胞开始出现凋亡,48小时凋亡明显.硼替佐米作用24小时后细胞周期明显阻滞在G0/G1期.Westemblot实验显示,80 nmol/L硼替佐米处理结肠癌SW480细胞后PTEN蛋白表达水平随时间明显增加,而p-Akt蛋白随时间表达下降.结论:硼替佐米可以抑制结肠癌SW480细胞增殖.其机制可能与抑制PTEN蛋白降解,抑制p-Akt途径有关.为结肠癌治疗药物的发展和更新提供了新的候选分子. 相似文献
7.
本研究为了探讨罗格列酮对人肝癌细胞QGY-7701增殖凋亡的影响,阐明其作用机制,以罗格列酮和人肝癌细胞QGY-7701为材料,通过结晶紫染色及CCK8方法,发现罗格列酮对人肝癌细胞QGY-7701有明显的抑制作用,其IC50为83.24μmol/L;通过RT-PCR,发现罗格列酮上调PTEN基因;通过Western blotting,发现罗格列酮能使PCNA、Bcl-2和p-Akt蛋白表达下调,使Bad、PPARγ和PTEN的蛋白表达上调,经PPARγ抑制剂处理后,PTEN和p-Akt表达下调。结果表明,罗格列酮可能通过调节PTEN/PI3K/AKT基因的途径,诱导人肝癌细胞QGY-7701凋亡,并抑制癌细胞的进一步增殖。本研究为临床肝癌研究提供理论基础。 相似文献
8.
目的:探讨胰岛素样生长因子-1(IGF-1)促血管平滑肌细胞(VSMC)增殖的细胞内信号转导机制.方法:体外培养的兔血管平滑肌细胞分3组处理,以细胞计数、噻唑盐比色法测定细胞增殖能力,以磷脂酰肌醇-3激酶(PI3K)特异性抑制剂渥漫青霉素(WT)孵育细胞间接反映PI3K作用.Western Blot定量磷酸酶PTEN表达水平,免疫沉淀、特异底物diC16PIP3绿色试剂法测定PTEN脂质磷酸酶活性.结果:IGF-1(100 μg/L)使细胞计数及MTT 比色A值分别增加至对照组的2.8倍和3.8倍,WT抑制VSMC增殖,并完全逆转IGF-1的作用(均P<0.01).各浓度IGF-1对PTEN蛋白表达水平无明显影响,其对PTEN活性的抑制呈浓度(10~100 μg/L)及时间(3 min~24 h)依赖性(均P<0.01).结论:IGF-1促VSMC增殖作用与活化PI3K蛋白激酶的促生长活性及抑制PTEN脂质磷酸酶的负性调节细胞生长作用有关. 相似文献
9.
目的:探讨软脂酸(PA)对胰岛β细胞(MIN6细胞)凋亡及Akt信号途径的影响。方法:细胞采用小鼠胰岛素瘤细胞株MIN6,不同浓度PA(0-1.6mmol/L)干预24、48h,MTT、法测定各组细胞存活率。干预48h后Hoechst-PI染色法和Annexin—V/PI双标流式测定法测定各组细胞凋亡率,Western-blot法测定p-Akt、Akt、Bax、Bcl-2。结果:随着PA浓度的增高①MIN6细胞存活率逐渐减小、凋亡率逐渐增大;②MIN6细胞中p-Akt和Bcl-2的表达逐渐减少,而Akt、Bax无明显改变。结论:长时间PA作用引起MIN6细胞凋亡,并呈现一定的量效关系;这一效应可能是通过Akt/Bcl-2产生作用的。 相似文献
10.
目的:研究土槿皮乙酸对人肾癌细胞A498凋亡的影响,并探讨其内在的分子机制,为肾癌治疗寻找有效的新靶点和新策略。方法:人肾癌细胞A498经10、15μmol/L土槿皮乙酸处理48 h后,用流式细胞仪检测细胞凋亡,同时通过Western印迹和实时荧光定量PCR检测凋亡相关蛋白和m RNA的表达;加入PI3K/Akt通路抑制剂LY294002或15μmol/L土槿皮乙酸处理A498细胞48 h后,Western印迹检测相关蛋白的表达。结果:经不同浓度土槿皮乙酸作用A498细胞48 h后,与未加土槿皮乙酸组细胞相比,细胞凋亡率显著上升,且呈剂量依赖性,比较差异有统计学意义(P0.05);同时,Blc-2表达减少,Bax、caspase-9、caspase-3表达增多。Blc-2蛋白的表达量随LY294002或土槿皮乙酸的逐步加入而减少,而Bax、caspase-9、caspase-3的表达呈增加趋势;PI3K和Akt蛋白的表达量与是否加入LY294002或土槿皮乙酸无关,p-PI3K和Aktp-Ser473蛋白的表达量随LY294002或土槿皮乙酸的逐步加入而减少。结论:土槿皮乙酸可抑制A498细胞凋亡,其作用机制可能与PI3K/Akt通路相关。 相似文献
11.
12.
《Translational oncology》2020,13(7):100769
OBJECTIVE: To improve conventional chemotherapeutic efficacy, it is significant to identify novel molecular markers for chemosensitivity as well as possible molecules accelerating cell-killing mechanisms. In this study, we attempted to elucidate how MK2206, an allosteric Akt inhibitor, enhances the cisplatin (CDDP)-induced cytotoxicity and apoptosis in testicular cancer. MATERIALS AND METHODS: We checked three testicular cancer cell lines for the expression of phospho(p)-Akt and its downstream molecules targets by Western blot. The potential antitumor effects were analyzed by MTT assay in vitro and by subcutaneous xenograft models in vivo. The cell invasion was analyzed by transwell invasion assay, and the activities of Akt signaling pathway and expression of apoptosis-related proteins were measured by Western blot. RESULTS: Our results indicated that there was overactivation of p-Akt and its downstream molecules in testicular cancer cell lines compared with normal testis epithelium cells. MK2206 (600 nM) inhibited cell invasion in TCAM-2 and P19 cell lines and significantly increased the susceptibility of testicular cancer to CDDP. Combined with CDDP, MK2206 potentiated CDDP-induced cytotoxicity and apoptosis, with repressed expression of p-Akt and its downstream targets. The subcutaneous xenograft models also showed that a combined CDDP/MK2206 therapy completely suppressed tumor growth without any side effects. CONCLUSION: These results suggested that the concomitant use of MK2206 could enhance the CDDP-induced cytotoxicity and apoptosis in testicular cancer with the suppressed expression of Akt pathway. 相似文献
13.
Chakrabhavi Dhananjaya Mohan V. Srinivasa Shobith Rangappa Lewis Mervin Surender Mohan Shardul Paricharak Sefer Baday Feng Li Muthu K. Shanmugam Arunachalam Chinnathambi M. E. Zayed Sulaiman Ali Alharbi Andreas Bender Gautam Sethi Basappa Kanchugarakoppal S. Rangappa 《PloS one》2016,11(4)
Overactivation of PI3K/Akt/mTOR is linked with carcinogenesis and serves a potential molecular therapeutic target in treatment of various cancers. Herein, we report the synthesis of trisubstituted-imidazoles and identified 2-chloro-3-(4, 5-diphenyl-1H-imidazol-2-yl) pyridine (CIP) as lead cytotoxic agent. Naïve Base classifier model of in silico target prediction revealed that CIP targets RAC-beta serine/threonine-protein kinase which comprises the Akt. Furthermore, CIP downregulated the phosphorylation of Akt, PDK and mTOR proteins and decreased expression of cyclin D1, Bcl-2, survivin, VEGF, procaspase-3 and increased cleavage of PARP. In addition, CIP significantly downregulated the CXCL12 induced motility of breast cancer cells and molecular docking calculations revealed that all compounds bind to Akt2 kinase with high docking scores compared to the library of previously reported Akt2 inhibitors. In summary, we report the synthesis and biological evaluation of imidazoles that induce apoptosis in breast cancer cells by negatively regulating PI3K/Akt/mTOR signaling pathway. 相似文献
14.
Kai Yao Junfeng Wu Jianfeng Zhang Jimei Bo Zhen Hong Hengbing Zu 《Cellular and molecular neurobiology》2016,36(5):801-809
Various useful animal models, such as Alzheimer’s disease and Niemann–Pick disease, were provided by U18666A. However, the pathogenesis of U18666A-induced diseases, including U18666A-mediated apoptosis, remains incompletely elucidated, and therapeutic strategies are still limited. Dihydrotestosterone (DHT) has been reported to contribute to the prevention and treatment of neurodegenerative disorders. Our study investigated the neuroprotective activity of DHT in U18666A-related diseases. Apoptosis of C6 cells was detected by Hoechst 33258 fluorescent staining and flow cytometry with annexin V-FITC/PI dual staining. Cell viability was assessed using Cell Counting Kit-8. Expression of apoptosis-related proteins, such as Akt, seladin-1, Bcl-2 family proteins, and caspase-3, was determined using Western blot. Our results demonstrated that the apoptotic rate of C6 cells significantly increased after U18666A addition, but was remarkably reduced after DHT treatment. Pretreatment with DHT attenuated U18666A-induced cell viability loss. PI3K inhibitor LY294002 could suppress DHT anti-apoptotic effect. Furthermore, we discovered that U18666A could significantly downregulate seladin-1 expression in a dose-dependent manner, but no significant change was observed in Bcl-xL, Bax, and P-Akt protein expressions. Compared with U18666A-treated group, the expression of P-Akt, seladin-1, and Bcl-xL significantly increased, and the expression of Bax and caspase-3 remarkably reduced after DHT treatment. However, in the presence of LY294002, the effect of DHT was reversed. In conclusion, we found that seladin-1 may take part in U18666A-induced apoptosis. DHT may inhibit U18666A-induced apoptosis by regulating downstream apoptosis-related proteins including seladin-1, caspase-3, Bcl-xL, and Bax through activation of the PI3K/Akt signal pathway. 相似文献
15.
目的:探讨Ras超家族的小G蛋白Ran GTPase在胰腺癌组织及细胞中的表达情况,及其对胰腺癌细胞PANC-1增殖和凋亡的影响.方法:选取胰腺癌石蜡标本及相应正常组织标本各27例进行免疫组织化学染色.用LipofectamineTM2000转染Ran干扰RNA (small interference RNA,siRNA)进入胰腺癌细胞系PANC-1干扰其表达,之后利用Western blot观察Ran的表达情况.运用MTT及流式细胞术分别检测各实验组细胞的增殖和凋亡情况.结果:免疫组化染色显示在胰腺癌组织中Ran的表达阳性率及得分均明显高于癌旁正常组织(P<0.05).将干扰Ran siRNA转染进入细胞系PANC-1中,利用Westemblot发现Ran的表达明显下调.并且通过MTT实验发现在胰腺癌细胞系PANC-1中下调Ran表达能明显抑制该细胞生长(P<0.05),并使PANC-1细胞凋亡显著增多(P<0.05).结论:小G蛋白Ran GTPase在胰腺癌组织及细胞系中高表达,且Ran可以促进胰腺癌细胞PANC-1的增殖,抑制其凋亡. 相似文献
16.
目的:探讨P13K特异性抑制剂LY294002逆转顺铂耐药口腔鳞癌细胞TCA8113/CDDP的可行性。方法:采用间歇性加药,逐步递增CDDP药量,体外连续诱导培养TCA8113/CDDP细胞;用不同浓度的LY294002和顺铂处理TCA8113和TCA8113/CDDP细胞;MTT法观察对细胞增殖的影响,Western印迹分析LY294002作用前后p-Akt、Akt、P13K蛋白的表达。结果:建立了舌鳞癌耐药细胞TCA8113/CDDP,耐药指数为7.7;MTT实验显示LY294002对TCA8113和TCA8113/CDDP细胞的抑制作用与浓度及作用时间呈正相关;LY294002联合顺铂对2种细胞的抑制作用比单用顺铂效果好;P13K、Akt、P—AKT蛋白表达明显降低,其中TCA8113/CDDP细胞中P13K、AKT、p-AKT蛋白的表达比TCA8113细胞明显增多(P〈0.05)。结论:LY294002能增加耐药口腔鳞癌顺铂化疗的敏感性。 相似文献
17.
Pancreatic cancer is an aggressive malignancy that is frequently diagnosed at an advanced stage with poor prognosis. Here, we report the chemotherapeutic effects of bioactive proanthocyanidins from grape seeds (GSPs) as assessed using In Vitro and In Vivo models. Treatment of human pancreatic cancer cells (Miapaca-2, PANC-1 and AsPC-1) with GSPs In Vitro reduced cell viability and increased G2/M phase arrest of the cell cycle leading to induction of apoptosis in a dose- and time-dependent manner. The GSPs-induced apoptosis of pancreatic cancer cells was associated with a decrease in the levels of Bcl-2 and Bcl-xl and an increase in the levels of Bax and activated caspase-3. Treatment of Miapaca-2 and PANC-1 cells with GSPs also decreased the levels of phosphatidylinositol-3-kinase (PI3K) and phosphorylation of Akt at ser(473). siRNA knockdown of PI3K from pancreatic cancer cells also reduced the phosphorylation of Akt. Further, dietary administration of GSPs (0.5%, w/w) as a supplemented AIN76A control diet significantly inhibited the growth of Miapaca-2 pancreatic tumor xenografts grown subcutaneously in athymic nude mice, which was associated with: (i) inhibition of cell proliferation, (ii) induction of apoptosis of tumor cells, (iii) increased expression of Bax, reduced expression of anti-apoptotic proteins and activation of caspase-3-positive cells, and (iv) decreased expression of PI3K and p-Akt in tumor xenograft tissues. Together, these results suggest that GSPs may have a potential chemotherapeutic effect on pancreatic cancer cell growth. 相似文献
18.
多项研究发现CXCR4在各种类型的癌症中高表达,然而尚不清楚CXCR4在食管癌细胞生长和转移中的作用。本研究检测了CXCR4在食管癌组织和细胞系(TE-1)中的表达,并通过转染CXCR4-短发夹RNA(CXCR4-sh RNA)慢病毒来敲低TE-1细胞中CXCR4的表达。应用PI3K/AKT抑制剂LY294002(50μmol/L)处理TE-1细胞12 h来考察AKT信号在食管癌细胞生长和转移中的作用;应用蛋白质印迹分析检测AKT和Rho家族蛋白(RhoA,Rac-1和Cdc42)的表达;应用CCK-8实验检测细胞增殖;Transwell实验检测细胞侵袭;对雄性BALB/c-nu/nu裸鼠皮下注射转染CXCR4-shRNA的TE-1细胞建立肿瘤异种移植模型。研究显示,CXCR4在食管癌组织中的表达水平明显高于癌旁组织,并且与TNM分期和淋巴结转移有关。CXCR4在人食管鳞状细胞癌细胞系(TE-1)中的表达水平明显高于人正常食管上皮细胞系(human normal esophageal epithelial cell line,HEEC)。敲低CXCR4能抑制食管鳞状细胞癌细胞的增殖和侵袭能力,并抑制肿瘤异种移植裸鼠的肿瘤形成。敲低CXCR4抑制了AKT的磷酸化及RhoA、Rac-1和Cdc42的表达。此外,PI3K/AKT抑制剂LY294002处理显著降低了TE-1细胞中AKT的磷酸化,并降低了RhoA、Rac-1和Cdc42的表达。本研究表明,CXCR4在食管癌患者中上调,与不良预后相关。下调CXCR4的表达可在体内和体外抑制食管癌肿瘤的生长和转移。下调CXCR4可通过抑制AKT信号的激活来抑制Rho家族粘附/侵袭相关蛋白的表达,从而抑制肿瘤转移。 相似文献